Share

April 2015; 2 (2) Clinical/Scientific NotesOpen Access

GABAA receptor and LGI1 antibody encephalitis in a patient with thymoma

Mateus Mistieri Simabukuro, Mar Petit-Pedrol, Luiz H. Castro, Ricardo Nitrini, Leandro Lucato, Antônio Alberto Zambon, Lis Gomes Silva, Gabriela Carneiro Rosa Fortes, Herval Ribeiro Soares Neto, Josep O. Dalmau
First published February 12, 2015, DOI: https://doi.org/10.1212/NXI.0000000000000073
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1455

Share

Article Information

vol. 2 no. 2 e73
DOI: 
https://doi.org/10.1212/NXI.0000000000000073
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received November 5, 2014
  • Accepted in final form December 31, 2014
  • First Published February 12, 2015.
Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Mateus Mistieri Simabukuro, MD*,
    2. Mar Petit-Pedrol, BS*,
    3. Luiz H. Castro, MD,
    4. Ricardo Nitrini, MD, PhD,
    5. Leandro Lucato, MD,
    6. Antônio Alberto Zambon, MD,
    7. Lis Gomes Silva, MD,
    8. Gabriela Carneiro Rosa Fortes, MD,
    9. Herval Ribeiro Soares Neto, MD and
    10. Josep O. Dalmau, MD, PhD
  1. Mateus Mistieri Simabukuro, MD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. (1) Private neurology practice in Samaritano Hospital

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. This work was supported in part by (1) National Institutes of Health grant RO1NS077851, (2) Fondo de Investigaciones Sanitarias grant PI11/01780(Dr Dalmau).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. This work was supported in part by (1) Fundació la Marató TV3

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Mar Petit-Pedrol, BS*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Luiz H. Castro, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. State of Sao Paulo (Brazil) Research Council - Process 05/56464-9 (Principal Investigator)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Ricardo Nitrini, MD, PhD,
    5. Scientific Advisory Boards:

    1. Advisory board meeting of Janssen-Cilag in 2012 Advisory meeting with Brazilian Nutricia board in 2013

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Funding for travel to Alzheimer Association International Congress. Novartis 2012 and 2013

    Editorial Boards:

    1. Editor - Dementia & Neuropsychologia 2007-present Editorial Board member- Alzheimer's Disease and Associated Disordes - 2004-present Editorial Board member - International Journal of Alzheimer's Disease 2011-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Speaker in a meeting sponsored by Novartis in 2012 peaker in a meeting sponsored by Danone (Nutricia) in 2013

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. I work in private clinic as clinical neurologist

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. FAPESP (Foundation for the support of research in the S?o Paulo State, Brazil) for epidemiology study on dementia in Brazil Federico Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Leandro Lucato, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Arquivos de Neuro-Psiquiatria, Associate editor (Neuroimaging), since 2010.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Antônio Alberto Zambon, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Lis Gomes Silva, MD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Gabriela Carneiro Rosa Fortes, MD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Herval Ribeiro Soares Neto, MD and
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Josep O. Dalmau, MD, PhD
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology, Neuroimmunology and Neuroinflammation Neurology UpToDate

    Patents:

    1. Patent for Ma2 autoantibody test, patent number: 6,387,639; Issued May 14th, 2002 Patent for NMDA receptor autoantibody test; US 7,972,796 B2 July 5, 2011; European 2057466 Patents filed for GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, and IgLON5 autoantibody test.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Advance Medical

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NMDAR autoantibody determination in the context of research.

    Research Support, Commercial Entities:

    1. Euroimmun, research support ISCIII

    Research Support, Government Entities:

    1. NIH, RO1NS077851 (previously RO1CA107192), PI, 2011-2016 NIH, RO1CA89054, PI, 2008-2013 Fondo de Investigaciones Sanitarias de la Seguridad Social (Spanish Government), 11/01780, PI, 2012-2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NMDA receptor autoantibody test/Euroimmun GABA(B)R autoantibody test/Euroimmun GABA(A)R autoantibody test/Euroimmun DPPX autoantibody test/Euroimmun Iglon5 autoantibody test/Euroimmun

    Royalty Payments, Technology or Inventions:

    1. Patent Ma2 autoantibody test Patent NMDAR autoantibody test Patent application for the use of GABA(B) receptor, GABA (A) receptor, DPPX and IgLON5 autoantiboddy tests

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Neurology Division (M.M.S., L.H.C., R.N., A.A.Z., L.G.S., G.C.R.F., H.R.S.N.) and Radiology Institute (L.L.), Hospital das Clínicas, São Paulo University, São Paulo, Brazil; August Pi i Sunyer Biomedical Research Institute (IDIBAPS) (M.P.-P., J.O.D.), Barcelona, Spain; Department of Neurology (J.O.D.), University of Pennsylvania, Philadelphia, PA; and Catalan Institution for Research and Advanced Studies (ICREA) (J.O.D.), Barcelona, Spain.
  1. Correspondence to Dr. Simabukuro: mateus.simabukuro{at}hc.fm.usp.br

Article usage

Article usage: February 2015 to November 2023

AbstractFullPdfSource
Feb 2015371617Highwire
Mar 2015701625Highwire
Mar 201505734pmc
Apr 201512715949Highwire
Apr 201503515pmc
May 2015402813Highwire
May 201504124pmc
Jun 201543185Highwire
Jun 201504120pmc
Jul 20153088Highwire
Jul 201502512pmc
Aug 201572416Highwire
Aug 201503117pmc
Sep 20153732Highwire
Sep 201503711pmc
Oct 20152172Highwire
Oct 20150294pmc
Nov 201515310Highwire
Nov 201503524pmc
Dec 20151526Highwire
Dec 20150246pmc
Jan 20163186Highwire
Jan 201602410pmc
Feb 20161765Highwire
Feb 20160213pmc
Mar 20163157Highwire
Mar 20160334pmc
Apr 20163345Highwire
Apr 20160419pmc
May 20162332Highwire
May 201603810pmc
Jun 20162872Highwire
Jun 20160254pmc
Jul 20162026Highwire
Jul 201603510pmc
Aug 20162348Highwire
Aug 20160396pmc
Sep 20162114Highwire
Sep 20160299pmc
Oct 201627112Highwire
Oct 20160497pmc
Nov 20161916Highwire
Nov 201606013pmc
Dec 20161214Highwire
Dec 201605811pmc
Jan 20171637Highwire
Jan 20170275pmc
Feb 201715320Highwire
Feb 20170403pmc
Mar 20171529Highwire
Mar 201704912pmc
Apr 2017575Highwire
Apr 201733242pmc
May 2017815Highwire
May 201754144pmc
Jun 2017943Highwire
Jun 2017103439pmc
Jul 2017730Highwire
Jul 201762931pmc
Aug 2017956Highwire
Aug 201763436pmc
Sep 2017911Highwire
Sep 201742929pmc
Oct 2017842Highwire
Oct 201743436pmc
Nov 20171354Highwire
Nov 201732629pmc
Dec 20172122Highwire
Jan 2018183Highwire
Feb 20182123Highwire
Mar 201811204Highwire
Apr 20186772Highwire
Apr 201831922pmc
May 20182694Highwire
Jun 20182514Highwire
Jun 201832022pmc
Jul 201813910Highwire
Aug 20185286Highwire
Aug 201841214pmc
Sep 201831711Highwire
Oct 20181334Highwire
Nov 20183282Highwire
Dec 20182874Highwire
Jan 20196352Highwire
Feb 20196283Highwire
Mar 2019104614Highwire
Apr 201911289Highwire
May 2019104710Highwire
Jun 201982811Highwire
Jul 20197665Highwire
Aug 201935012Highwire
Sep 20194155Highwire
Oct 201953310Highwire
Nov 20199153Highwire
Dec 201917299Highwire
Jan 20207439Highwire
Feb 2020102112Highwire
Mar 2020101316Highwire
Apr 20200193Highwire
May 20200236Highwire
Jun 20200265Highwire
Jul 20201252Highwire
Aug 20202216Highwire
Sep 20205247Highwire
Oct 202022710Highwire
Nov 20201209Highwire
Dec 20204183Highwire
Jan 20212168Highwire
Feb 20211259Highwire
Mar 2021111812Highwire
Apr 20214255Highwire
May 20213268Highwire
Jun 20214283Highwire
Jul 202113317Highwire
Aug 20214459Highwire
Sep 20211127Highwire
Oct 202122827Highwire
Nov 202121816Highwire
Dec 20214266Highwire
Jan 20224352Highwire
Feb 20225198Highwire
Mar 20222246Highwire
Apr 202202311Highwire
May 202213815Highwire
Jun 20221299Highwire
Jul 20224235Highwire
Aug 20222226Highwire
Sep 202232517Highwire
Oct 20222257Highwire
Nov 202217721Highwire
Dec 20223197Highwire
Jan 20232456Highwire
Feb 20232234Highwire
Mar 20231145Highwire
Apr 20231183Highwire
May 20230147Highwire
Jun 2023263Highwire
Jul 2023288Highwire
Aug 202331712Highwire
Sep 202321610Highwire
Oct 20230184Highwire
Nov 20230143Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles